FDANonrulemakingFDA-2016-D-1270
Who commented on this docket
Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases
14 organizations filed 15 public comments on Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases, at the Food and Drug Administration. The comment window closed 3582d ago.
Organizations
14
Comments
15
RIN
—
Comment window
closed 3582d ago
Commenters (14)
- Advanced Medical Technology Associationtrade assoc.2 filings · confidence 97%
- American Association for Cancer Researchtrade assoc.1 filing · confidence 85%
- American Association for Clinical Chemistrytrade assoc.1 filing · confidence 85%
- American Clinical Laboratory Associationtrade assoc.1 filing · confidence 85%
- American Medical Associationtrade assoc.1 filing · confidence 97%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- American Society of Hematologytrade assoc.1 filing · confidence 85%
- American Society of Human Geneticstrade assoc.1 filing · confidence 85%
- Association for Molecular Pathologytrade assoc.1 filing · confidence 85%
- Genentech Incunverified attribution1 filing · confidence 70%
- Leukemia & Lymphoma Societytrade assoc.1 filing · confidence 85%
- Personalized Medicine Coalitiontrade assoc.1 filing · confidence 85%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
- The Coalition for 21st Century Medicinetrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.